TLDR:
– Hippocratic AI received a $17 million investment from Nvidia’s VC arm and other investors to develop generative AI healthcare agents.
– The startup has raised a total of $137 million, with a valuation of $500 million, to enhance personalized patient interactions.
Three months ago, startup Hippocratic AI rolled out its initial commercial product, a generative AI-based, task-specific healthcare agent, and partnered with Nvidia to develop large language models for healthcare. This collaboration has now led to Nvidia’s venture capital arm, NVentures, Greycroft, and Lee Shapiro of 7Wire Ventures collectively investing $17 million in an add-on to Hippocratic AI’s extended Series A round. This brings the startup’s total funding to $137 million, with a series A round boosting its valuation to $500 million.
Hippocratic AI, founded by Munjal Shah, aims to create a safety-focused large language model for healthcare to address staffing shortages. The company’s generative AI-powered agents can carry out non-diagnostic, patient-facing roles, such as pre-operative care, chronic management, and pharmaceutical trial coordination. Through rigorous safety testing involving clinicians, nurses, and licensed professionals, the company ensures the AI agents meet specific criteria for patient interaction.
With the recent investment, Hippocratic AI plans to further enhance its product, develop new use cases, and optimize speed and safety. The company’s focus on providing abundant healthcare, coupled with empathetic AI healthcare agents designed for natural interactions, aligns with Nvidia’s goal of revolutionizing healthcare through generative AI technology.
